Tandem Diabetes Care Inc (NASDAQ:TNDM) hit a preliminary home run with its first quarter earnings show for 2018, releasing an exciting revenue beat …
Canaccord’s Mark Massaro now bets on 50% in return potential for the healthcare player.
Riot Blockchain Inc (NASDAQ:RIOT) shares are on a tear today, plunging 30% in the market after the worst kind of publicity has hit …
Canaccord’s Mark Massaro is impressed that even after recent HTGM share volatility, the healthcare player still delivered an impressive robust fourth quarter turnout for 2017.
Even though Cantor’s William Tanner slices his price target, he nonetheless angles for almost 115% whopping upside potential for AGRX shares.
Cantor’s William Tanner believes the key fact of the matter is that Twirla does not use CORI’s Corplex technology; the CRL just impacts the contraceptive patch manufacturer’s short-term revenue prospects.
Canaccord’s Kyle Rose is impressed that not only did HSGX achieve its goal to nab a partnership by the year’s end, but the partner in Japan is a stellar choice with experience in regenerative medicine.
Atossa Genetics may have taken a beating in the market yesterday after investors ran for the hills with fears of share dilution running …
Avinger Inc (NASDAQ:AVGR) trumpets the news today of the healthcare player’s submission to the FDA of a new 510(k) application for its next …
Shares of breast cancer detection device makerĀ Atossa Genetics Inc (NASDAQ:ATOS) are tumbling nearly 23%, as of this writing. The reason?